C. Pickering

Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors

K. Niewola-Staszkowska, M. Deken, O. Peyruchaud, 2023, Immuno-oncology technology.

Highly Selective Allosteric Modulator of the Phosphoinositide 3‐Kinase Delta (PI3Kδ) Roginolisib In Patients With Refractory/Relapsed Follicular Lymphoma

C. Tarantelli, F. Bertoni, T. Hammett, 2023, Hematological Oncology.